Orion Oyj (OTCMKTS:ORINF – Get Free Report) traded up 3.2% during mid-day trading on Wednesday . The stock traded as high as $48.65 and last traded at $48.65. 200 shares changed hands during trading, a decline of 81% from the average session volume of 1,080 shares. The stock had previously closed at $47.16.
Orion Oyj Stock Performance
The company has a 50-day moving average of $47.16 and a 200-day moving average of $47.16.
Orion Oyj Company Profile
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Recommended Stories
- Five stocks we like better than Orion Oyj
- What is the Hang Seng index?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Penny Stocks Ready to Break Out in 2025
- Quiet Period Expirations Explained
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Orion Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
